Additional information
Pale yellow Powder
182627-95-8
ACI-020814
>300°C
C11H11BrN5O2Cl
360.6
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
5-Bromo-6-(imidazoldine-2-ylidinanine)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
5-Bromo-6-(imidazoldine-2-ylidinanine)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
Brimonidine-2,3-dione





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)